Cargando…

The Association between Three Cyclooxygenase-2 Polymorphisms and Hepatocellular Carcinoma Risk: A Meta-Analysis

BACKGROUND: A quantity of case-control studies have been performed to address the association between three cyclooxygenase-2(COX-2) polymorphisms (-1195G/A, -765G/C and +8473T/C) and the risk of hepatocellular carcinoma (HCC). However, previous research results are inconsistent. We conducted this me...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Zhigang, Zhu, Jiye, Huang, Chaoyuan, Lian, Fang, Wu, Guobin, Zhao, Yinnong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4346398/ https://www.ncbi.nlm.nih.gov/pubmed/25730260 http://dx.doi.org/10.1371/journal.pone.0118251

Ejemplares similares

Development and validation of an RNA binding protein-associated prognostic model for hepatocellular carcinoma
por: Wang, Min, et al.
Publicado: (2020)

Prognostic significance of cyclooxygenase-2 expression in patients with hepatocellular carcinoma: a meta-analysis
por: Chen, Guodong, et al.
Publicado: (2016)

Molecular subtyping and IMScore based on immune-related pathways, oncogenic pathways, and DNA damage repair pathways for guiding immunotherapy in hepatocellular carcinoma patients
por: Yu, Zeyan, et al.
Publicado: (2022)

The Association between MTHFR Gene Polymorphisms and Hepatocellular Carcinoma Risk: A Meta-Analysis
por: Qin, Xue, et al.
Publicado: (2013)

Associations between three XRCC1 polymorphisms and hepatocellular carcinoma risk: A meta-analysis of case-control studies
por: Xiong, Yao, et al.
Publicado: (2018)

The association of three promoter polymorphisms in interleukin-10 gene with the risk for colorectal cancer and hepatocellular carcinoma: A meta-analysis
por: Shi, Yan-Hui, et al.
Publicado: (2016)

Hepatic cyclooxygenase-2 overexpression induced spontaneous hepatocellular carcinoma formation in mice
por: Chen, H, et al.
Publicado: (2017)

Cyclooxygenase-2 Polymorphisms and Susceptibility to Colorectal Cancer: A Meta-Analysis
por: Wang, Jun, et al.
Publicado: (2013)

Evaluation of epigenetic modulation of cyclooxygenase-2 as a prognostic marker for hepatocellular carcinoma
por: Fernández-Alvarez, A, et al.
Publicado: (2012)

Association between cyclooxygenase-2 (COX-2) 8473 T > C polymorphism and cancer risk: a meta-analysis and trial sequential analysis
por: Li, Qiuping, et al.
Publicado: (2018)

Suppressing growth and invasion of human hepatocellular carcinoma cells by celecoxib through inhibition of cyclooxygenase-2
por: Tai, Yang, et al.
Publicado: (2019)

Relationship between cyclooxygenase 8473T>C polymorphism and the risk of lung cancer: a case-control study
por: Park, Jung Min, et al.
Publicado: (2006)

Association between the methylenetetrahydrofolate reductase C677T polymorphism and hepatocellular carcinoma risk: a meta-analysis
por: Jin, Fei, et al.
Publicado: (2009)

Association between Two Common Polymorphisms and Risk of Hepatocellular Carcinoma: Evidence from an Updated Meta-Analysis
por: Wang, Zhaoming, et al.
Publicado: (2014)

Association between COX-2 gene polymorphisms and risk of hepatocellular carcinoma development: a meta-analysis
por: Lu, Si-Cong, et al.
Publicado: (2015)

Association between cyclin D1 G870A polymorphism and hepatocellular carcinoma risk: a meta-analysis
por: Luo, Tao, et al.
Publicado: (2016)

Cyclooxygenase-2 and vascular endothelial growth factor in chronic hepatitis, cirrhosis and hepatocellular carcinoma
por: Kwon, Soon Ha, et al.
Publicado: (2012)

Meta-Analysis of Microsomal Epoxide Hydrolase Gene Polymorphism and Risk of Hepatocellular Carcinoma
por: Zhong, Jian-Hong, et al.
Publicado: (2013)

XPD Polymorphisms and Risk of Hepatocellular Carcinoma and Gastric Cancer: A Meta-Analysis
por: Zhou, Qiang, et al.
Publicado: (2021)

Association between three VEGF polymorphisms and renal cell carcinoma susceptibility: a meta-analysis
por: Hou, Qi, et al.
Publicado: (2017)

Associations between methylenetetrahydrofolate reductase polymorphisms and hepatocellular carcinoma risk: An update meta-analysis and trial sequential analysis
por: Wang, Binfeng, et al.
Publicado: (2021)

Single nucleotide polymorphism of rs2596542 and the risk of hepatocellular carcinoma development: A meta-analysis
por: Kuang, Xue-Jun, et al.
Publicado: (2019)

Associations between single-nucleotide polymorphisms of human exonuclease 1 and the risk of hepatocellular carcinoma
por: Tan, Shengkui, et al.
Publicado: (2016)

Prevalence of sarcopenia among patients with hepatocellular carcinoma: A systematic review and meta‑analysis
por: Liu, Jiye, et al.
Publicado: (2023)

Knockdown of cyclooxygenase-2 leads to growth inhibition and cell cycle arrest in hepatocellular carcinoma cells
por: Lv, Xiuhe, et al.
Publicado: (2019)

miR-136 Inhibits Malignant Progression of Hepatocellular Carcinoma Cells by Targeting Cyclooxygenase 2
por: Jia, Haiyan, et al.
Publicado: (2018)

Combined Effects of Cyclooxygenase-1 and Cyclooxygenase-2 Selective Inhibitors on Ovarian Carcinoma in Vivo
por: Li, Wei, et al.
Publicado: (2011)

The association of TNF-308 (G/A) gene polymorphisms and hepatocellular carcinoma risk: a meta-analysis
por: Sun, Qing, et al.
Publicado: (2016)

Epidermal Growth Factor Gene Polymorphism and Risk of Hepatocellular Carcinoma: A Meta-Analysis
por: Zhong, Jian-Hong, et al.
Publicado: (2012)

Interferon-γ +874A/T Polymorphism and Hepatocellular Carcinoma Risk: A Meta-Analysis
por: Zhou, Huan, et al.
Publicado: (2015)

Colorectal Carcinoma, Cyclooxygenases, and COX Inhibitors
por: Ganduri, Vinutna, et al.
Publicado: (2022)

The Association between Two Common Polymorphisms in MicroRNAs and Hepatocellular Carcinoma Risk in Asian Population
por: Hu, Miao, et al.
Publicado: (2013)

Systematic Review and Meta-Analysis on the Association between Polymorphisms in Genes of IL-12 Signaling Pathway and Hepatocellular Carcinoma Risk
por: Xiao, Yao, et al.
Publicado: (2018)

Associations between hepatocellular carcinoma risk and rs3212227 and rs568408 polymorphisms: a systematic review and meta-analysis
por: Kong, Cunqing, et al.
Publicado: (2020)

Association between sarcopenia and clinical outcomes in patients with hepatocellular carcinoma: an updated meta-analysis
por: Guo, Yusheng, et al.
Publicado: (2023)

Association between four common microRNA polymorphisms and the risk of hepatocellular carcinoma and HBV infection
por: KOU, JIAN-TAO, et al.
Publicado: (2014)

Clinicopathological features and differential diagnosis of hepatocellular carcinoma in extrahepatic metastases
por: Chen, Dingbao, et al.
Publicado: (2018)

Cyclooxygenase-2 inhibitor is a robust enhancer of anticancer agents against hepatocellular carcinoma multicellular spheroids
por: Cui, Jie, et al.
Publicado: (2014)

Suppressing Growth and Invasion of Human Hepatocellular Carcinoma Cells by Celecoxib Through Inhibition of Cyclooxygenase-2 [Corrigendum]
Publicado: (2021)

Aberrant Lipid Metabolism in Hepatocellular Carcinoma Revealed by Liver Lipidomics
por: Li, Zhao, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_t5hv8les2p4glgcqfqmbke9qfk